Default company panoramic image


Terapio is a VC backed, government funded biopharmaceutical company developing the RLIP76 protein for biodefense and commercial applications

  • Stage Product In Development
  • Industry Biotechnology
  • Location Austin, TX, USA
  • Currency USD
  • Founded January 2006
  • Employees 11
  • Website

Company Summary

Terapio is a biopharmaceutical company developing therapeutics based on the RLIP76 protein. The lead application is a medical countermeasure for radiation exposure for civilian, military, first responder and astronaut/flight crew populations in addition to other defense and clinical indications. RLIP76 works though the oxidative stress pathway and is efficacious as both a prophylactic and mitigator by effluxing toxins from the cell.


  • Default avatar
    Curt Bilby, PhD
    President and CEO

  • Default avatar
    Casey Cunningham, MD
    Co-founder and Chief Medical Officer

  • Default avatar
    Henry Hebel
    VP of Drug Development

  • Default avatar
    Elizabeth Leffel, PhD, MPH
    VP Preclinical/Nonclinical Programs

Previous Investors

  • Default avatar
    Santé Ventures
    Default avatar
    State of Texas